NO20010030D0 - Use of prenyltransferase inhibitors for the manufacture of a medicament for the treatment of pathologies resulting from heterotrimeric G-protein membrane fixation - Google Patents

Use of prenyltransferase inhibitors for the manufacture of a medicament for the treatment of pathologies resulting from heterotrimeric G-protein membrane fixation

Info

Publication number
NO20010030D0
NO20010030D0 NO20010030A NO20010030A NO20010030D0 NO 20010030 D0 NO20010030 D0 NO 20010030D0 NO 20010030 A NO20010030 A NO 20010030A NO 20010030 A NO20010030 A NO 20010030A NO 20010030 D0 NO20010030 D0 NO 20010030D0
Authority
NO
Norway
Prior art keywords
heterotrimeric
medicament
manufacture
treatment
protein membrane
Prior art date
Application number
NO20010030A
Other languages
Norwegian (no)
Other versions
NO20010030L (en
Inventor
Gregoire Prevost
Marie-Odile Lonchampt
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO20010030D0 publication Critical patent/NO20010030D0/en
Publication of NO20010030L publication Critical patent/NO20010030L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20010030A 1998-07-08 2001-01-03 Use of prenyltransferase inhibitors for the manufacture of a medicament for the treatment of pathologies resulting from heterotrimeric G-protein membrane fixation NO20010030L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9808730A FR2780892B1 (en) 1998-07-08 1998-07-08 USE OF PRENYLTRANSFERASE INHIBITORS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR TREATING CONDITIONS RESULTING FROM MEMBRANE FIXATION OF HETEROTRIMERIC PROTEIN
PCT/FR1999/001611 WO2000002558A1 (en) 1998-07-08 1999-07-05 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation

Publications (2)

Publication Number Publication Date
NO20010030D0 true NO20010030D0 (en) 2001-01-03
NO20010030L NO20010030L (en) 2001-01-08

Family

ID=9528404

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010030A NO20010030L (en) 1998-07-08 2001-01-03 Use of prenyltransferase inhibitors for the manufacture of a medicament for the treatment of pathologies resulting from heterotrimeric G-protein membrane fixation

Country Status (7)

Country Link
EP (1) EP1094810A1 (en)
JP (1) JP2002520284A (en)
AU (1) AU4622499A (en)
CA (1) CA2337261A1 (en)
FR (1) FR2780892B1 (en)
NO (1) NO20010030L (en)
WO (1) WO2000002558A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420555B1 (en) 1998-06-16 2002-07-16 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Imidazolyl derivatives
DE10235385B4 (en) * 2002-08-02 2006-10-05 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for the chromatographic separation of components
EP1618874A2 (en) * 2003-04-30 2006-01-25 Consejo Superior De Investigaciones Cientificas Prevention of hiv-1 infection by inhibition of rho-mediated reorganisation and/or content alteration of cell membrane raft domains
JP4339739B2 (en) 2004-04-26 2009-10-07 太陽誘電株式会社 Multi-layer board with built-in components
CN114380848B (en) * 2020-10-19 2023-03-14 华南农业大学 Preparation and application of isoquinoline thiazole salt and derivatives thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0763537A3 (en) * 1993-05-14 1997-10-22 Genentech Inc Non-peptidyl Ras farnesyl transferase inhibitors
JPH09500109A (en) * 1993-06-18 1997-01-07 メルク エンド カンパニー インコーポレーテッド Inhibitors of farnesyl protein transferase
HUT77406A (en) * 1994-03-15 1998-04-28 Eisai Co., Ltd., Peptidomimetics containing 1-(4-amino-5-thiopent-2-en)-yl side chain and pharmaceutical compositions thereof
US5523430A (en) * 1994-04-14 1996-06-04 Bristol-Myers Squibb Company Protein farnesyl transferase inhibitors
US5510510A (en) * 1994-05-10 1996-04-23 Bristol-Meyers Squibb Company Inhibitors of farnesyl protein transferase
US5491164A (en) * 1994-09-29 1996-02-13 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU4915796A (en) * 1995-01-12 1996-07-31 University Of Pittsburgh Inhibitors of prenyl transferases
US5534537A (en) * 1995-03-29 1996-07-09 Merck & Co., Inc. Prodrugs of inhibitors of farnesyl-protein transferase
US5627202A (en) * 1995-03-29 1997-05-06 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0840605A4 (en) * 1995-07-13 2000-05-10 Univ Cincinnati Compounds useful in the treatment of neurofibromatosis
TW349948B (en) * 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
WO1997017321A1 (en) * 1995-11-07 1997-05-15 Banyu Pharmaceuticals Co., Ltd. Cyclic amic acid derivatives
CA2238081A1 (en) * 1995-11-22 1997-05-29 S. Jane Desolms Inhibitors of farnesyl-protein transferase
ES2175137T3 (en) * 1995-12-08 2002-11-16 Janssen Pharmaceutica Nv DERIVATIVES OF (IMIDAZOL-5-IL) METHYL-2-QUINOLINONE AS INHIBITORS OF LAPROTEIN FARNESIL-TRANSFERASE.
WO1997027752A1 (en) * 1996-01-30 1997-08-07 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2250232A1 (en) * 1996-04-03 1997-10-09 Allen I. Oliff A method of treating cancer
JP2000507597A (en) * 1996-04-03 2000-06-20 メルク エンド カンパニー インコーポレーテッド Farnesyl protein transferase inhibitor
AU716153B2 (en) * 1996-04-03 2000-02-17 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2251955A1 (en) * 1996-04-18 1997-10-23 Nancy E. Kohl A method of treating cancer
US5773455A (en) * 1996-06-28 1998-06-30 Biomeasure, Incorporated Inhibitors of prenyl transferases

Also Published As

Publication number Publication date
WO2000002558A1 (en) 2000-01-20
CA2337261A1 (en) 2000-01-20
FR2780892A1 (en) 2000-01-14
JP2002520284A (en) 2002-07-09
EP1094810A1 (en) 2001-05-02
NO20010030L (en) 2001-01-08
FR2780892B1 (en) 2001-08-17
AU4622499A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
DE60023068D1 (en) Pawl mechanism for surgical instruments
DE50008336D1 (en) MULTILAYER TABLET FOR THE ADMINISTRATION OF A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
DE60101201D1 (en) USE OF NICOTINERGEN ACETYLCHOLIN RECEPTOR AGONISTS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF KERATOCONJUCTIVITIS SICCA
CL2003001814A1 (en) COMPOUNDS DERIVED FROM 1,3,8-TRIAZAESPIRO [4,5] DECAN-4-ONA JIDROXIALQUIL SUBSTITUTED, MODULATORS OF THE ORL-1 RECEIVER; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPOUNDS; COMPOSITION PREPARATION PROCEDURE F
DE59900101D1 (en) Medical instrument for tissue preparation
HUP9701694A3 (en) Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds
TWI315204B (en) Oral dosage forms for propiverine or pharmaceutically acceptable salts thereof having prolonged release of the active agent
NO20020770D0 (en) Use of monoamine oxidase inhibitors for the manufacture of drugs suitable for the treatment of obesity
NO20006630D0 (en) Pharmaceutical composition for the treatment of diabetes
NO20023765L (en) Use of central cannabinoid receptor antagonists for the manufacture of medicaments useful for promoting stop tobacco use
DE50010287D1 (en) MEDICAL OR TECHNICAL ENDOSCOPIC INSTRUMENT
ATE484494T1 (en) SUBSTITUTED INDOLE DERIVATIVES FOR A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES
AU2002215223A1 (en) Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts
DE50004173D1 (en) SURGICAL TUBE INSTRUMENT
IL213809A0 (en) Use of derivatives of n-phenylpiperazin-1-yl-acetamide for the preparation of a pharmaceutical compositions for treatment of diabetes related conditions
DE50004193D1 (en) MEDICAL INSTRUMENT
NO20020574D0 (en) Substituted 1,5-dihydropyrrole-2-derivatives which act as NMDA receptor antagonists for the treatment of the pain state
PL375964A1 (en) Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis
NO20010029L (en) Use of cysteine derivatives for the manufacture of a medicament for the treatment of pathologies resulting from the formation of heterotrimerized G protein
NO20010030D0 (en) Use of prenyltransferase inhibitors for the manufacture of a medicament for the treatment of pathologies resulting from heterotrimeric G-protein membrane fixation
ITMI20001051A0 (en) FORMULATIONS CONTAINING A GLUCOCORTICOSTEROID DRUG FOR THE TREATMENT OF BRONCHOPULMONARY DISEASES
NO972141D0 (en) Disposable dental floss dispenser
IL206566A0 (en) Use of an antagonist to the igs4 neuromedin receptor polypeptide for the preparation of a medicament for the treatment of a disease related to the expression or acitivity of the igs4 neuromedin receptor polypeptide
DK1241949T3 (en) RELEASE OF LIPOFILE ACTIVE SUBSTANCES FROM CHEMICAL GUM
DE50012014D1 (en) USE OF A PHARMACEUTICAL COMPOSITION CONTAINING DESOXYPEGANINE FOR THE TREATMENT OF NICOTINE DEPENDENCE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application